Skip to main content

Advertisement

Log in

Trehalose does not affect the functions of human neutrophils in vitro

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

Trehalose, naturally occurring disaccharide, has been reported to prevent postoperative abdominal adhesions in animal models. We investigated whether trehalose affects the function of human polymorphonuclear neutrophils (PMNs) in vitro to assess the feasibility of its clinical application as an anti-adhesive barrier.

Methods

Human PMNs were obtained from 17 healthy volunteers. Escherichia coli and Staphylococcus aureus were used for the bacterial infection model, whereas lipopolysaccharide (LPS) and interleukin (IL)-1β were used for inflammation induction model. The PMN phagocytosis rates of bacteria and apoptosis/necrosis were assessed on trehalose, maltose, and control media. Cytokines; namely, tumor necrosis factor-α, IL-1α, IL-1Ra, IL-6, and IL-8; and PMN-elastase were measured on each medium in both models.

Results

There were no significant differences in the phagocytosis rates, apoptosis/necrosis rates, or levels of all cytokines or PMN-elastase among the three media in the bacterial infection model. There were also no significant differences in the levels of all cytokines and PMN-elastase among the three media in the IL-1β inflammation induction model. PMN-elastase was lower in trehalose and maltose medium after LPS stimulation, at 3 and 24 h.

Conclusions

Our results suggest that trehalose does not affect the cellular function, cytokine production, or release of PMN-elastase of human PMNs in an in vitro bacterial infection model.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

TNF-α:

Tumor necrosis factor-α

IL-1α:

Interleukin-1α

IL-1Ra:

IL-1 receptor antagonist

LPS:

Lipopolysaccharide

References

  1. Liakakos T, Thomakos N, Fine PM, Dervenis C, Young RL. Peritoneal adhesions: etiology, pathophysiology, and clinical significance. Recent advances in prevention and management. Dig Surg. 2001;18:260–73.

    Article  CAS  PubMed  Google Scholar 

  2. Ward BC, Panitch A. Abdominal adhesions: current and novel therapies. J Surg Res. 2011;165:91–111.

    Article  PubMed  Google Scholar 

  3. Wiseman DM. Adhesion related disease—adhesions related deaths. 2003. http://www.adhesion.org.

  4. Wilson MS. Practicalities and costs of adhesions. Colorectal Dis. 2007;9:60–5.

    Article  PubMed  Google Scholar 

  5. Fazio VW, Cohen Z, Fleshman JW, van Goor H, Bauer JJ, Wolff BG, et al. Reduction in adhesive small-bowel obstruction by Seprafilm adhesion barrier after intestinal resection. Dis Colon Rectum. 2006;49:1–11.

    Article  PubMed  Google Scholar 

  6. Yamaoka T, Takahashi Y, Fujisato T, Lee CW, Tsuji T, Ohta T, et al. Novel adhesion prevention membrane based on a bioresorbable copoly(ester-ether) comprised of poly-l-lactide and pluronic: in vitro and in vivo evaluations. J Biomed Mater Res. 2001;54:470–9.

    Article  CAS  PubMed  Google Scholar 

  7. Diamond MP, Freeman ML. Clinical implications of postsurgical adhesions. Hum Reprod Update. 2001;7:567–76.

    Article  CAS  PubMed  Google Scholar 

  8. Kusunoki M, Ikeuchi H, Yanagi H, Noda M, Tonouchi H, Mohri Y, et al. Bioresorbable hyaluronate–carboxymethylcellulose membrane (Seprafilm) in surgery for rectal carcinoma: a prospective randomized clinical trial. Surg Today. 2005;35:940–5.

    Article  PubMed  Google Scholar 

  9. Mohri Y, Uchida K, Araki T, Inoue Y, Tonouchi H, Miki C, et al. Hyaluronic acid–carboxycellulose membrane (Seprafilm) reduces early postoperative small bowel obstruction in gastrointestinal surgery. Am Surg. 2005;71:861–3.

    PubMed  Google Scholar 

  10. Inoue M, Uchida K, Miki C, Kusunoki M. Efficacy of Seprafilm for reducing reoperative risk in pediatric surgical patients undergoing abdominal surgery. J Pediatr Surg. 2005;40:1301–6.

    Article  PubMed  Google Scholar 

  11. Ouaïssi M, Gaujoux S, Veyrie N, Denève E, Brigand C, Castel B, et al. Post-operative adhesions after digestive surgery: their incidence and prevention: review of the literature. J Visc Surg. 2012;149:e104–14.

    Article  PubMed  Google Scholar 

  12. Kamel RM. Prevention of postoperative peritoneal adhesions. Eur J Obstet Gynecol Reprod Biol. 2010;150:111–8.

    Article  PubMed  Google Scholar 

  13. Elbein AD, Pan YT, Pastuszak I, Carroll D. New insights on trehalose: a multifunctional molecule. Glycobiology. 2003;13:17R–27R.

    Article  CAS  PubMed  Google Scholar 

  14. Chen Q, Haddad GG. Role of trehalose phosphate synthase and trehalose during hypoxia: from flies to mammals. J Exp Biol. 2004;207:3125–9.

    Article  CAS  PubMed  Google Scholar 

  15. Ohtake S, Wang YJ. Trehalose: current use and future applications. J Pharm Sci. 2011;100:2020–53.

    Article  CAS  PubMed  Google Scholar 

  16. Lee S, Miwa Y, Nishimura R, Chung UI, Suzuki S, Sasaki N. Effects of trehalose and sodium carboxymethyl cellulose on prevention of organ adhesion after laparotomy: a preliminary study. Jpn J Vet Anesth Surg. 2009;40:19–26.

    Article  Google Scholar 

  17. Fujino H, Lee S, Suzuki S, Chung UI, Mochizuki M, Nishimura R, et al. Trehalose may prevent postsurgical adhesions in a rabbit model of hysterotomy. J Vet Med Sci. 2011;73:931–5.

    Article  PubMed  Google Scholar 

  18. Ohata A, Iwata K, Tamura N, Nojima H, Tanei S. Adhesion-reducing effects of trehalose formulation in the rabbit cecal and abdominal wall abrasion model. J Abdom Emerg Med. 2011;31:434 (Japanese).

    Google Scholar 

  19. Lim R, Morrill JM, Lynch RC, Reed KL, Gower AC, Leeman SE, et al. Practical limitations of bioresorbable membranes in the prevention of intra-abdominal adhesions. J Gastrointest Surg. 2009;13:35–41.

    Article  PubMed  Google Scholar 

  20. Uchida K, Urata H, Mohri Y, Inoue M, Miki C, Kusunoki M. Seprafilm does not aggravate intraperitoneal septic conditions or evoke systemic inflammatory response. Surg Today. 2005;35:1054–9.

    Article  CAS  PubMed  Google Scholar 

  21. Otake K, Uchida K, Yoshiyama S, Inoue M, Okita Y, Watanabe H, et al. Effects of a hyaluronate–carboxymethylcellulose membrane (Seprafilm) on human polymorphonuclear neutrophil functions. J Surg Res. 2008;149:243–9.

    Article  CAS  PubMed  Google Scholar 

  22. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89.

    PubMed  Google Scholar 

  23. Zysk G, Bejo L, Schneider-Wald BK, Nau R, Heinz H. Induction of necrosis and apoptosis of neutrophil granulocytes by Streptococcus pneumoniae. Clin Exp Immunol. 2000;122:61–6.

    CAS  PubMed Central  PubMed  Google Scholar 

  24. Turina M, Miller FN, McHugh PP, Cheadle WG, Polk HC Jr. Endotoxin inhibits apoptosis but induces primary necrosis in neutrophils. Inflammation. 2005;29:55–63.

    Article  CAS  PubMed  Google Scholar 

  25. Abbott PJ, Chen J. Trehalose. WHO food additive series 46. http://www.inchem.org/documents/jecfa/jecmono/v46je05.htm. Accessed December 22, 2010.

  26. Esmann L, Idel C, Sarkar A, Hellberg L, Behnen M, Möller S, et al. Phagocytosis of apoptotic cells by neutrophil granulocytes: diminished proinflammatory neutrophil functions in the presence of apoptotic cells. J Immunol. 2010;184:391–400.

    Article  CAS  PubMed  Google Scholar 

  27. Ho SC, Lee KY, Chan YF, Kuo LW, Ito K, Adcock IM, et al. Neutrophil elastase represses IL-8/CXCL8 synthesis in human airway smooth muscle cells through induction of NF-kappa B repressing factor. J Immunol. 2009;183:411–20.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was funded by Otsuka Pharmaceutical Factory, Inc. (Tokushima, Japan). Trehalose and maltose were supplied by Otsuka Pharmaceutical Factory, Inc.

Conflict of interest

Masato Kusunoki consults to other clinical trials about the efficacy and safety of trehalose in the prevention of postsurgical adhesion formation conducted by Otsuka Pharmaceutical Factory, Inc. (Tokushima, Japan). Masato Kusunoki received a research grant for this study from Otsuka Pharmaceutical Factory, Inc.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Koji Tanaka.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tanaka, K., Kawamura, M., Otake, K. et al. Trehalose does not affect the functions of human neutrophils in vitro. Surg Today 44, 332–339 (2014). https://doi.org/10.1007/s00595-013-0625-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-013-0625-2

Keywords

Navigation